Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmacogenomic Data “Regulatory Impact” To Be Outlined In Guidance

Executive Summary

The regulatory impact of different categories of pharmacogenomic data will be addressed in a draft guidance, Center for Drug Evaluation & Research Director Janet Woodcock, MD, said at FDA's Science Board Advisory Committee meeting April 9

You may also be interested in...



Pharmacogenomics draft guidance

FDA is understood to be on track to release its pharmacogenomics draft guidance in August. The draft guidance is understood to state that FDA will not require sponsors to collect pharmacogenomics data for product applications (1"The Pink Sheet" April 14, 2003, p. 12). The Drug Information Association is planning a meeting on pharmacogenomics for November...

Pharmacogenomics draft guidance

FDA is understood to be on track to release its pharmacogenomics draft guidance in August. The draft guidance is understood to state that FDA will not require sponsors to collect pharmacogenomics data for product applications (1"The Pink Sheet" April 14, 2003, p. 12). The Drug Information Association is planning a meeting on pharmacogenomics for November...

FDA Pharmacogenomic Regulation: Three Guidances, Fall Workshop

FDA is planning to issue three guidances on pharmaco-genomics over the next 18 months

Related Content

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel